Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for patients with COVID-19 of the Proposal of Diagnosis and Treatment of COVID-19; (2) Aged 18-85 years; (3) To agree to participate in the study and sign the informed consent
Exclusion criteria
Exclusion criteria: (1) Critical patients; (2) TCM diagnosis of yang deficiency syndrome, manifested as limb warm, thin stools, chills, etc.; (3) Patients who cannot guarantee compliance during treatment, and patients who are difficult to administer by oral or nasal route; (4) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19; (5) Pregnant and mothers, those who have a pregnancy plan, and those who have a positive urine pregnancy test; (6) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study; (7) People who have been allergic to Chinese medicine or intolerant to taking medicine. (8) Patients are participating in other COVID-19 clinical trials.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Total hospitalized time;side effects associated with interventions; | — |
Primary
| Measure | Time frame |
|---|---|
| Inflammation absorption on Chest CT; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine